8.54

0.12% -0.01

Chimerix Inc (CMRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$8.55

Offen:

$8.55

24-Stunden-Volumen:

755.34K

Relative Volume:

0.20

Marktkapitalisierung:

$354.50M

Einnahmen:

$324.00K

Nettoeinkommen (Verlust:

$-82.10M

KGV:

-9.1828

EPS:

-0.93

Netto-Cashflow:

$-69.18M

1W Leistung:

+0.00%

1M Leistung:

+0.00%

6M Leistung:

+926.44%

1J Leistung:

+808.80%

1-Tages-Spanne:

$8.54

$8.55

1-Wochen-Bereich:

$8.54

$8.55

52-Wochen-Spanne:

$0.75

$8.55

Chimerix Inc Stock (CMRX) Company Profile

Firmenname

Chimerix Inc

Sektor

Healthcare (1170)

Branche

Biotechnology (667)

Telefon

919.806.1074

Adresse

2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC

Mitarbeiter

Twitter

@chimerix

Nächster Verdiensttermin

2025-03-21

Neueste SEC-Einreichungen

CMRX's Discussions on Twitter

Vergleichen Sie CMRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CMRX Chimerix Inc	8.54	354.50M	324.00K	-82.10M	-69.18M	-0.93
VRTX Vertex Pharmaceuticals Inc	450.50	113.52B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	493.22	52.93B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	300.83	39.71B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	585.93	35.00B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	255.86	26.57B	3.81B	-644.79M	-669.77M	-6.24

Chimerix Inc Stock (CMRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-05-23	Eingeleitet	Robert W. Baird	Outperform
2022-09-07	Eingeleitet	CapitalOne	Overweight
2021-04-29	Eingeleitet	Maxim Group	Buy
2021-04-23	Fortgesetzt	Cowen	Outperform
2021-03-31	Eingeleitet	Jefferies	Buy
2021-03-31	Eingeleitet	Wedbush	Outperform
2018-02-14	Herabstufung	JP Morgan	Neutral → Underweight
2018-02-02	Eingeleitet	H.C. Wainwright	Buy
2016-08-09	Bestätigt	FBR Capital	Mkt Perform
2016-02-23	Herabstufung	Barclays	Overweight → Equal Weight
2016-02-23	Bestätigt	FBR Capital	Mkt Perform
2016-02-23	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2016-02-22	Herabstufung	Citigroup	Buy → Neutral
2015-12-29	Herabstufung	JP Morgan	Overweight → Neutral
2015-12-28	Herabstufung	FBR Capital	Outperform → Mkt Perform
2015-12-28	Bestätigt	Piper Jaffray	Overweight
2015-12-17	Eingeleitet	UBS	Buy
2015-10-05	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2015-09-03	Eingeleitet	Citigroup	Buy
2015-08-18	Eingeleitet	FBR Capital	Outperform
2015-08-06	Bestätigt	Brean Capital	Buy
2015-05-11	Bestätigt	Brean Capital	Buy
2015-03-04	Eingeleitet	Barclays	Overweight
2015-02-12	Bestätigt	Stifel	Buy
2014-12-31	Bestätigt	Brean Capital	Buy
2014-07-08	Fortgesetzt	Brean Capital	Buy

Alle ansehen

Chimerix Inc Aktie (CMRX) Neueste Nachrichten

May 28, 2025

CHIMERIX Earnings Preview: Recent $CMRX Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 28, 2025

May 27, 2025

Northern Trust Corp Sells 36,038 Shares of Chimerix, Inc. (NASDAQ:CMRX) - Defense World

May 27, 2025

May 26, 2025

Chimerix, Inc. (NASDAQ:CMRX) Shares Purchased by Millennium Management LLC - Defense World

May 26, 2025

May 19, 2025

Balyasny Asset Management L.P. Purchases Shares of 60,317 Chimerix, Inc. (NASDAQ:CMRX) - Defense World

May 19, 2025

May 18, 2025

Chimerix (NASDAQ:CMRX) Now Covered by StockNews.com - Defense World

May 18, 2025

May 10, 2025

StockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX) - Defense World

May 10, 2025

May 02, 2025

Halper Sadeh LLP, bluebird bio, Inc., Walgreens Boots Alliance, Chimerix, Inc. - Olean Times Herald

May 02, 2025

Chimerix (NASDAQ:CMRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 02, 2025

Apr 30, 2025

Geode Capital Management LLC Lowers Stock Holdings in Chimerix, Inc. (NASDAQ:CMRX) - Defense World

Apr 29, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 22, 2025

Jazz Pharmaceuticals Acquires Chimerix for $935M - Contract Pharma

Apr 22, 2025

Apr 21, 2025

Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix - marketscreener.com

Apr 21, 2025

Jazz Pharmaceuticals acquires Chimerix for $935 million By Investing.com - Investing.com South Africa

Apr 21, 2025

Chimerix Terminates Loan and Delists from Nasdaq - TipRanks

Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ St - GuruFocus

Apr 21, 2025

Jazz Pharmaceuticals (JAZZ) Completes Acquisition of Chimerix - StreetInsider

Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix - TipRanks

Apr 21, 2025

Jazz Pharmaceuticals acquires Chimerix for $935 million - Investing.com

Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ Stock News - GuruFocus

Apr 21, 2025

Jazz's $935M Chimerix Buyout Targets First-Ever Treatment for Rare Brain Cancer, FDA Verdict Looms - Stock Titan

Apr 21, 2025

Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 By Investing.com - Investing.com South Africa

Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 - Investing.com

Apr 10, 2025

Apr 07, 2025

Unlocking Investment Potential Discover the Power of Magical Signals Bullish Signal - AInvest

Apr 07, 2025

Top 3 Health Care Stocks That May Crash In Q2 - Benzinga

Apr 07, 2025

Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 By Investing.com - Investing.com Australia

Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 - Investing.com

Apr 02, 2025

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - MSN

Apr 02, 2025

Apr 01, 2025

Jazz Pharmaceuticals, Chimerix HSR waiting period expired on March 31 - MLex

Apr 01, 2025

Mar 31, 2025

11 Best Performing NASDAQ Stocks So Far in 2025 - Insider Monkey

Mar 31, 2025

Exploring US High Growth Tech Stocks In March 2025 - simplywall.st

Mar 31, 2025

Mar 26, 2025

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo

Mar 26, 2025

Mar 24, 2025

11 Best Performing Stocks So Far In 2025 - Insider Monkey

Mar 24, 2025

Jazz strikes the chord with $935m Chimerix acquisition - BioXconomy

Mar 24, 2025

Chimerix Reports 2024 Losses Amid Acquisition News - TipRanks

Mar 24, 2025

Mar 21, 2025

Chimerix earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada

Mar 21, 2025

Chimerix Inc Reports Q4 2024 EPS of -$0.25, Beating Estimates; R - GuruFocus.com

Mar 21, 2025

The buildup to Chimerix's $935M exit to Jazz, with more than half a dozen parties intrigued - Endpoints News

Mar 21, 2025

Chimerix: Q4 Earnings Snapshot - mySA

Mar 21, 2025